Virtual Mindfulness Rounds in the Time of COVID-19 Pandemic
The Impact of Virtual Mindfulness Education Sessions on Staff Perceived Stress During COVID-19
1 other identifier
interventional
15
1 country
1
Brief Summary
Mindfulness education will be provided via a virtual platform to see if staff stress can be decreased during this time of pandemic.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 12, 2020
CompletedFirst Posted
Study publicly available on registry
June 16, 2020
CompletedStudy Start
First participant enrolled
March 22, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 14, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 14, 2021
CompletedAugust 20, 2021
August 1, 2021
2 months
June 12, 2020
August 19, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Perceived Stress Scale
Participants will file a 10 question validated survey tool call the Perceived Stress Scale (PSS) before and after the 4-week virtual educational intervention. Total scale range from 0 to 40, higher score indicates more perceived stress
baseline and Week 6
Study Arms (1)
Health Care Workers
OTHERVoluntary participation in the virtual presentations
Interventions
Virtually delivered mindfulness education sessions of 15-30 minutes, two times/week, for four weeks
Eligibility Criteria
You may qualify if:
- Mount Sinai Hospital employee
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Icahn School of Medicine at Mount Sinai
New York, New York, 10029, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Jeffrey Zahn, MD
Icahn School of Medicine at Mount Sinai
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
June 12, 2020
First Posted
June 16, 2020
Study Start
March 22, 2021
Primary Completion
May 14, 2021
Study Completion
May 14, 2021
Last Updated
August 20, 2021
Record last verified: 2021-08